Maynard Um
-
-
-
-
-
-
-
Raymond James on Biohaven Pharma (BHVN) with shares up 7%: 'Promising Degrader Data Sets Ahead of R&D Day'
-
-
-
-
-
-
-
Biohaven Pharma (BHVN) PT Raised to $17 at Citi
-
-
-
-
-
-
-
Biohaven Pharma (BHVN) Tops Q4 EPS by 28c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Neutral Rating on Biohaven Pharmaceutical Holding (BHVN)
-
-
-
-
-
-
-
William Blair Reiterates Market Perform Rating on Biohaven Pharmaceutical Holding (BHVN)
-
-
-
-
-
-
-
William Blair Downgrades Biohaven Pharmaceutical Holding (BHVN) to Market Perform
-
-
-
-
-
-
-
Truist: 'QURE Update Minimal Read-Through To PTCT & WVE, In Our View'
-
415,794 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

